• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过主成分分析对慢性阻塞性肺疾病进行表型分析:临床聚类的识别

Phenotyping Chronic Obstructive Pulmonary Disease Through Principal Component Analysis: Identification of Clinical Clusters.

作者信息

Mekov Evgeni V, Yanev Nikolay A, Kurtelova Nedelina, Mihalova Teodora, Tsakova Adelina, Yamakova Yordanka, Petkov Rosen E

机构信息

Department of Pulmonary Diseases, Medical University-Sofia, Sofia, BGR.

Central Clinical Laboratory, Medical University-Sofia, Alexandrovska University Hospital, Sofia, BGR.

出版信息

Cureus. 2025 Apr 22;17(4):e82811. doi: 10.7759/cureus.82811. eCollection 2025 Apr.

DOI:10.7759/cureus.82811
PMID:40416176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12098176/
Abstract

Introduction Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with varied clinical presentations and prognoses. Identifying patient phenotypes is essential for developing personalized treatment strategies. Principal component analysis (PCA) is a statistical method that can be employed to uncover clinical clusters and gain insight into the relationships among different disease characteristics. This study aims to analyze COPD patient phenotypes using PCA and to identify the key clinical features influencing their distribution. Materials and methods This was a prospective, observational outpatient study involving 96 patients diagnosed with COPD. Data collected included demographic, clinical, spirometric, echocardiographic, laboratory, and functional parameters. PCA was applied to reduce data dimensionality and to identify the principal components underlying phenotype structure. Results The first two principal components accounted for 62% of the total variance, underscoring the clinical heterogeneity of COPD. Visualization of the PCA revealed four distinct clusters that align with recognized COPD phenotypes: chronic bronchitis, emphysema, COPD with asthmatic features (previously referred to as asthma-COPD overlap), and the non-exacerbator type. Each cluster was associated with specific clinical characteristics. Conclusions PCA enabled the identification of four distinct clinical clusters among COPD patients: bronchitis, emphysema, COPD with asthmatic features, and non-exacerbator. This approach helps clarify the relationship between clinical characteristics and supports a more personalized approach to treatment.

摘要

引言 慢性阻塞性肺疾病(COPD)是一种具有多种临床表现和预后的异质性疾病。识别患者表型对于制定个性化治疗策略至关重要。主成分分析(PCA)是一种统计方法,可用于揭示临床聚类并深入了解不同疾病特征之间的关系。本研究旨在使用PCA分析COPD患者表型,并确定影响其分布的关键临床特征。材料和方法 这是一项前瞻性观察性门诊研究,纳入了96例诊断为COPD的患者。收集的数据包括人口统计学、临床、肺功能、超声心动图、实验室和功能参数。应用PCA降低数据维度,并确定表型结构的主要成分。结果 前两个主成分占总方差的62%,突出了COPD的临床异质性。PCA可视化显示了四个不同的聚类,与公认的COPD表型一致:慢性支气管炎、肺气肿、具有哮喘特征的COPD(以前称为哮喘-COPD重叠)和非加重型。每个聚类都与特定的临床特征相关。结论 PCA能够识别COPD患者中的四个不同临床聚类:支气管炎、肺气肿、具有哮喘特征的COPD和非加重型。这种方法有助于阐明临床特征之间的关系,并支持更个性化的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/318e/12098176/baad148d966a/cureus-0017-00000082811-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/318e/12098176/70999d81867c/cureus-0017-00000082811-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/318e/12098176/baad148d966a/cureus-0017-00000082811-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/318e/12098176/70999d81867c/cureus-0017-00000082811-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/318e/12098176/baad148d966a/cureus-0017-00000082811-i02.jpg

相似文献

1
Phenotyping Chronic Obstructive Pulmonary Disease Through Principal Component Analysis: Identification of Clinical Clusters.通过主成分分析对慢性阻塞性肺疾病进行表型分析:临床聚类的识别
Cureus. 2025 Apr 22;17(4):e82811. doi: 10.7759/cureus.82811. eCollection 2025 Apr.
2
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.慢性阻塞性肺疾病 - 稳定期疾病的诊断和管理;基于临床表型的可治疗特征概念,采用个体化护理方法。捷克肺病和结核学会立场文件。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056.
3
Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".西班牙慢性阻塞性肺疾病(COPD)表型患病率及分布的地理差异:“ESPIRAL-ES研究”
Int J Chron Obstruct Pulmon Dis. 2018 Apr 10;13:1115-1124. doi: 10.2147/COPD.S158031. eCollection 2018.
4
Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.根据西班牙慢性阻塞性肺疾病指南在临床实践中对慢性阻塞性肺疾病表型的识别与分布:FENEPOC研究
Int J Chron Obstruct Pulmon Dis. 2017 Aug 9;12:2373-2383. doi: 10.2147/COPD.S137872. eCollection 2017.
5
[PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].[个性化医疗:慢性阻塞性肺疾病的治疗]
Rev Med Liege. 2015 May-Jun;70(5-6):310-5.
6
Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study.慢性阻塞性肺疾病表型的临床转归。一项中心前瞻性研究。
Adv Respir Med. 2021;89(4):369-377. doi: 10.5603/ARM.a2021.0086.
7
Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.马来西亚农村地区 COPD 患者的临床表型和健康相关生活质量 - 一项横断面研究。
BMC Pulm Med. 2020 Sep 29;20(1):254. doi: 10.1186/s12890-020-01295-4.
8
Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.慢性阻塞性肺疾病的临床表型与健康相关生活质量:一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:565-573. doi: 10.2147/COPD.S196109. eCollection 2019.
9
Comparative Study of Systemic Inflammatory Markers in Clinical Phenotypes of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病临床表型中全身炎症标志物的比较研究
Tanaffos. 2023 Feb;22(2):215-220.
10
Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study.COPD 的临床表型及其对生活质量的影响:一项横断面研究。
Respir Med. 2023 Dec;220:107452. doi: 10.1016/j.rmed.2023.107452. Epub 2023 Nov 7.

本文引用的文献

1
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.2020-50 年全球 204 个国家和地区慢性阻塞性肺疾病的全球经济负担:一项健康增强型宏观经济建模研究。
Lancet Glob Health. 2023 Aug;11(8):e1183-e1193. doi: 10.1016/S2214-109X(23)00217-6.
2
A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups.一项针对尘肺病队列中慢性阻塞性肺疾病的聚类分析确定了三个亚组。
BMC Pulm Med. 2017 Dec 16;17(1):209. doi: 10.1186/s12890-017-0553-9.
3
Principal component analysis: a review and recent developments.
主成分分析:综述与最新进展
Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202. doi: 10.1098/rsta.2015.0202.
4
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.在ECLIPSE队列中使用聚类分析识别出五个具有不同预后的慢性阻塞性肺疾病亚组。
Ann Am Thorac Soc. 2015 Mar;12(3):303-12. doi: 10.1513/AnnalsATS.201403-125OC.
5
Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities.在患有多种合并症的慢性阻塞性肺疾病(COPD)患者中使用聚类分析识别临床表型。
Biomed Res Int. 2014;2014:420134. doi: 10.1155/2014/420134. Epub 2014 Feb 10.
6
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.临床慢性阻塞性肺疾病表型:一种使用主成分和聚类分析的新方法。
Eur Respir J. 2010 Sep;36(3):531-9. doi: 10.1183/09031936.00175109. Epub 2010 Jan 14.
7
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).慢性阻塞性肺疾病纵向评估以识别预测性替代终点(ECLIPSE)。
Eur Respir J. 2008 Apr;31(4):869-73. doi: 10.1183/09031936.00111707. Epub 2008 Jan 23.